The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro Extreme Fatigue vs Wegovy — What the Evidence Shows
Both Mounjaro (tirzepatide) and Wegovy (semaglutide) can cause fatigue as a side effect, though fatigue is reported less commonly than nausea or digestive symptoms. This guide compares how fatigue presents with each medication, the underlying mechanisms that may contribute to tiredness, and how clinical trial data differs between the two. Understanding these differences helps you discuss options with your prescriber when considering prescription weight loss treatment in the UK.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Clinical Trial Data and Fatigue Reporting: Mounjaro vs Wegovy
Fatigue (tiredness or lack of energy) is reported as a common side effect with both medications, though exact prevalence varies between clinical trials.
- Mounjaro (SURMOUNT-1 trial): Fatigue reported in approximately 7–10% of participants across all doses, typically described as mild to moderate and often improving after the first 4 weeks as the body adjusts to the medication
- Wegovy (STEP-1 trial): Fatigue reported in approximately 6–8% of participants, with similar patterns of improvement over time
The difference in reported fatigue rates is relatively small between the two medications. Mounjaro's dual mechanism (GIP + GLP-1 receptor agonist) versus Wegovy's single GLP-1 mechanism does not appear to significantly increase fatigue risk in clinical data. When fatigue does occur, it is usually linked to rapid dose increases, dehydration, or the body's metabolic adjustment to reduced calorie intake rather than the medication mechanism itself.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Why Fatigue Occurs and Individual Suitability Factors
Fatigue with weight loss medications can arise from several causes: rapid changes in metabolism as your body adapts to lower calorie intake, electrolyte imbalance from reduced food consumption, dehydration (both medications slow gastric emptying which can reduce fluid intake), or rapid dose escalation without adequate adjustment time.
Your prescriber will consider your individual health profile when choosing between Mounjaro and Wegovy. Factors include: existing fatigue or energy disorders, other medications that may interact, dose escalation tolerance, and your personal weight loss goals. Neither medication is universally "better" for avoiding fatigue — suitability is individual. If you experience extreme fatigue on either medication, contact your prescriber; dose adjustment or temporary holding may help. Use our free GLP-1 weight loss calculator to explore potential outcomes with both options, and discuss findings with your GP or licensed prescriber during your clinical assessment.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is fatigue more common with Mounjaro than Wegovy?
Clinical trial data shows fatigue is slightly more commonly reported with Mounjaro (7–10%) than Wegovy (6–8%), but the difference is small. Fatigue with both medications is typically mild to moderate and often improves within the first 4 weeks as your body adjusts. Your prescriber can help assess which option suits your individual tolerance.
What causes extreme fatigue on Mounjaro or Wegovy?
Extreme fatigue is usually linked to rapid dose increases, dehydration, low calorie intake without adequate nutrition, or electrolyte imbalance—not the medication mechanism itself. If you experience extreme tiredness, contact your prescriber immediately. They may adjust your dose, slow your escalation schedule, or recommend dietary changes.
Can I prevent fatigue when starting Mounjaro or Wegovy?
Yes. Stay well hydrated, eat nutrient-dense foods within your reduced-calorie intake, avoid very low calorie diets without medical supervision, and allow at least 4 weeks between dose increases. Your prescriber may recommend a slower titration schedule if you're at higher risk of fatigue.
How long does fatigue last on these medications?
Most people report fatigue improving within 4–8 weeks of starting or after dose adjustment. If fatigue persists beyond 8 weeks, inform your prescriber—it may indicate an underlying issue unrelated to the medication that needs investigation.
Should I choose Wegovy over Mounjaro to avoid fatigue?
The fatigue risk difference is minimal between the two. Your prescriber will recommend the medication best suited to your overall health profile, weight loss goals, and other medical factors—not based on fatigue risk alone. Both require UK prescription and clinical assessment before use.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.